VEGFA and hepatocellular carcinoma: According to the median IHC scores of YTHDF2, PD‐L1 and VEGFA, we classified HCC patients into three subgroups: 1) YTHDF2low, PD‐L1low and VEGFAlow (n = 22); 2) YTHDF2high, PD‐L1high and VEGFAhigh (n = 31); and 3) “the other group” (n = 36), which included the remaining samples.